A Rare Type of Myeloma: A Case of Monoclonal IgD-Lambda

An immunoglobulin D-multiple myeloma (IgD-MM) case represents a rare subtype of MM that is often observed in male patients under 65 years of age with an advanced stage at the time of diagnosis. It exhibits an aggressive course and is associated with a short survival period. In IgD-MM, an increase in lambda light chain proteins is expected. Given that IgD and IgE heavy chains are not routinely assessed in standard serum and serum immunofixation electrophoresis (IFE) analyses in MM patients, such cases may be misclassified and monitored as light chain myeloma. Therefore, distinguishing IgD or IgE myeloma from light chain myeloma represents a critical differential diagnosis. This case highlights the necessity of including IgD and IgE in diagnostic evaluations to prevent misclassification as light chain myeloma.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-03-24
DOI
https://doi.org/10.7759/cureus.81089
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Rare Type of Myeloma: A Case of Monoclonal IgD-Lambda

Erdal Kurtoğlu, Volkan Karakuş, Recep Kaya, Alperen Burak Kocabıyık
Cureus
Multiple Myeloma Research and Treatments
article

A Rare Type of Myeloma: A Case of Monoclonal IgD-Lambda

Erdal Kurtoğlu, Volkan Karakuş, Recep Kaya, Alperen Burak Kocabıyık
article en

Abstract

An immunoglobulin D-multiple myeloma (IgD-MM) case represents a rare subtype of MM that is often observed in male patients under 65 years of age with an advanced stage at the time of diagnosis. It exhibits an aggressive course and is associated with a short survival period. In IgD-MM, an increase in lambda light chain proteins is expected. Given that IgD and IgE heavy chains are not routinely assessed in standard serum and serum immunofixation electrophoresis (IFE) analyses in MM patients, such cases may be misclassified and monitored as light chain myeloma. Therefore, distinguishing IgD or IgE myeloma from light chain myeloma represents a critical differential diagnosis. This case highlights the necessity of including IgD and IgE in diagnostic evaluations to prevent misclassification as light chain myeloma.

CureusVol. 17(3)
Antalya Eğitim ve Araştırma Hastanesi (TR)
Openalex Percentile: Top 92%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.